COMP <GO>
CDTG vs CUVL // REVENUE GROWTH (YOY)
CDT Environmental Technology Investment Holdings Limited (NASDAQ) VS. Clinuvel Pharmaceuticals Limited (NASDAQ) • 15-METRIC TALLY: CDTG 1
— CUVL 7
▲ REVENUE GROWTH (YOY) LEADER: CUVL
LAST: $0.94 (-7.84%) • MKT CAP: $2.8M
revenue-growth
-38.80%
LAST: $5.15 (+1.58%) • MKT CAP: $257.8M
revenue-growth
5.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDTG VS. CUVL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDTG | CUVL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.50% | 81.20% | -39.70 | CUVL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -30.10% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 10.51% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 43.40% | -103.40 | CUVL | /operating-margins <GO> |
| Net Profit Margin | -55.90% | 37.80% | -93.70 | CUVL | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -38.80% | 5.50% | -44.30 | CUVL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.66% | -0.66 | CUVL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.38 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | CUVL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.3 | 37.7 | +1.65 | CDTG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 10.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.8M | $257.8M | -$255.0M | CUVL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDTG REV | CUVL REV | CDTG GROSS % | CUVL GROSS % | CDTG FCF | CUVL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.2M | $61.1M | 41.5% | 81.2% | -$1.5M | $27.1M |
| FY 2024 | $29.8M | $57.9M | 37.8% | 81.5% | -$2.0M | $20.1M |
| FY 2023 | $34.2M | — | — | — | -$3.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDTG // BETA —
CUVL // BETA —